.
In conclusion, a single bout of exercise appears to improve glucose handling by splanchnic tissues in NIDDM patients.
Effects of Strict Glycemic Regulation with Prandial Regular Insulin Injections on Hepatic
Glucose Uptake in Non-obese NIDDM Patients with Secondary Failure on Sulfonylureas The authors have previously reported that NIDDM is characterized by decreased meal-related insulin secretion (1) . Recently, we also demonstrated that sufficient insulin supplementation before each meal in NIDDM patients prevented beta cell exhaustion and was followed by restoration of endogenous basal insulin secretion (2) .
Taking all these results into consideration, it would appear that the substitution of prandial insulin by injections of regular insulin before each meal is essential.
The following working hypothesis, as the basis for a treatment regimen for non-obese NIDDM patients with secondary failure on sulfonylureas, has been proposed (Fig . 3) . The raised portal insulin concentration obtained by sufficient regular insulin supplementation before each meal, and the subsequently obtained normalization of pre-meal glycemia , which establishes the hepato-portal-arterial glucose gradient prandially , might together augment hepatic glucose uptake. Through these mechanisms, normallization of post-meal glycemia would be realized. Sufficient insulin supplementation before each meal prevents 
DISCUSSION
Regarding the factors that regulate hepatic glucose uptake, we have, firstly, reported that portally-administered insulin enhanced hepatic glucose uptake to a much greater degree than the same amount of insulin administered peripherally (3) .
Secondly, we showed that the amount of glucose taken up by the liver after glucose loading depends on the route of glucose administration and that hepatic removal of glucose is greater after portal glucose infusion than after peripheral glucose delivery (4) . Even though the exact mechanism of this phenomenon is not clearly understood, the arterial-portall venous glucose gradient has been speculated to be an important signal for augmenting hepatic glucose disposal We also demonstrated that this phenomenon(4) cannot be explained by portal and hepatic arterial glucose gradients. Therefore , to elucidate this phenomenon, we investigated the significance of the glucose gradient between the central nervous and hepatoportal systems in hepatic glucose uptake. This investigation was carried out in normal dogs with pulsed Doppler flow probes chronically implanted on the portal vein (PV) and hepatic artery (HA) and cannulae in the hepatic vein (HV), superior mesenteric vein (SMV), and PV. Intravenous glucose loading was performed according to the following 4 protocols;l) PE: peripheral infusion (7 mg/kg/min), 2) PO: intraportal infusion via SMV (same amount as PE), 3) PO+CNS: portal infusion (same as PO) plus additional glucose infusion into unilateral carotid (CA) and vertebral arteries (VA) to abolish the glucose gradient between the CNS and the hepatoportal system (amounts of glucose infused into the CA and VA were calculated based on the plasma flow ratio of PV to CA and VA), and 4) PO+PE: the same amount of additional glucose was infused into the peripheral vein instead of into the CNS. Net hepatic glucose balance (NHGB) and hepatic extraction of glucose (HERG) were calculated from plasma flows and plasma glucose levels in the PV, HA, and HV.
In PE and PO+CNS, the hepatopartal-CNS glucose gradients had negative and almost zero values,respectively. In PO and PO+PE, on the other hand, the hepatoportal -CNS glucose gradients had positive values. Glucose infusion via the portal route caused a significant increase in both NHGB and HERG compared to PE under comparable levels of plasma glucose and IRI. This increase in hepatic glucose uptake significantly decreased during PO+CNS, but returned to a value similar to that of PO during PO+PE . These results suggest that the glucose gradient between the CNS and the hepatoportal system appears to play a crucial role in regulating hepatic glucose disposal .
Then, to examine the effects of prevailing plasma glucose levels on hepatic glucose handling, hepatic glucose uptake during intraportal glucose infusion (7mg/kg/min) was measured under euglycemic (EUGL) and hyperglycemic (HYPGL) clamp conditions in Vol 
